Journal of Medicinal Chemistry · 2004 · 111 citations · 17 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoverySynthetic Medicinal ChemistryDna ChemistryHeterocyclic ChemistryLigand BindingLigand-based DesignAromatic HeterocyclesHeterocycle AromaticityHeterocycle ReactivityMedicinal Heterocycles
Amonafide- and elinafide-related mono and bisintercalators, modified by the introduction of a pi-excedent furan or thiophene ring fused to the naphthalimide moiety, have been synthesized. These compounds have shown an interesting antitumor profile. The best compound, 9, was 2.5-fold more potent than elinafide against human colon carcinoma cells (HT-29). Molecular dynamic simulations and physicochemical experiments have demonstrated that these compounds are capable of forming stable DNA complexes. These results, together with those previously reported by us for imidazo- and pyrazinonaphthalimide analogues, have prompted us to propose that the DNA binding process does not depend on the electronic nature of the fused heterocycle.
17
Michael Cory, David D. McKee, J. Kagan et al. · Journal of the American Chemical Society · 1985 · 429 citations